The Biosimilar Pipeline is Bursting with Possibilities

from tHEORetically Speaking: The HealthEconomics.Com Blog at on March 29, 2017 at 03:08PM

Biosimilarpipeline recently reported more than 700 biosimilars currently in development with more than 660 companies involved in the biosimilar land rush. The number of biosimilars in development however, far exceeds the number of agents that will be approved in the near future. Find out more here. (Source: Thomas Reinke, Managed Care)